Understanding Ischemic Heart Disease in Women: Risks, Symptoms, and the Need for Early Detection from Young Adulthood to Menopause

Ischemic heart disease in women often goes unrecognized or inadequately treated, according to recent medical commentary highlighting persistent gaps in diagnosis and care. This issue remains a significant concern in cardiovascular health, particularly as ischemic heart disease continues to be a leading cause of morbidity and mortality among women globally.

Dr. Teresa Padró, a medical expert cited in recent health reporting, emphasized that ischemic heart disease in women can be overlooked or not managed appropriately, contributing to delayed interventions and poorer outcomes. Her comments underscore the need for heightened awareness among both patients and healthcare providers regarding the unique presentation of heart disease in women.

Research indicates that women may experience different symptoms than men during cardiac events, which can contribute to misdiagnosis or under-treatment. While chest pain remains a common symptom, women are more likely to report atypical signs such as fatigue, shortness of breath, nausea, back or jaw pain, and dizziness. These variations can lead to both patients and clinicians failing to recognize the signs of a heart attack or underlying ischemic heart disease.

Studies have shown that biological and physiological differences between sexes influence how ischemic heart disease develops and presents. Factors such as hormonal changes, microvascular dysfunction, and disparities in traditional risk factor assessment contribute to the distinct profile of heart disease in women. For instance, conditions like endometriosis, polycystic ovary syndrome, and pregnancy-related complications have been linked to increased cardiovascular risk later in life.

The period between pregnancy and menopause represents a critical window for cardiovascular risk assessment in women. During this time, hormonal shifts and metabolic changes can accelerate the development of atherosclerosis and other precursors to ischemic heart disease. However, many women in this age group are not routinely screened for heart disease risk, despite accumulating evidence that early intervention could prevent future events.

Efforts to improve outcomes have focused on increasing awareness of sex-specific symptoms, refining diagnostic tools to better detect microvascular angina — more common in women — and ensuring that treatment guidelines are applied equitably. Cardiac rehabilitation programs, lipid management, and blood pressure control are equally important for women but are sometimes underutilized due to misperceptions about lower risk.

Public health initiatives continue to stress the importance of recognizing heart disease as a major threat to women’s health, challenging the outdated perception that it is primarily a male condition. Campaigns encouraging women to discuss cardiovascular concerns with their providers and seek timely evaluation for symptoms are seen as key steps toward reducing disparities in care.

While progress has been made in understanding the unique aspects of ischemic heart disease in women, gaps remain in clinical practice, research inclusion, and public awareness. Addressing these disparities requires sustained efforts from healthcare systems, policymakers, and communities to ensure that women receive timely, accurate, and effective care for heart disease across all stages of life.